Key result
Wideband LGE CMR changes diagnosis in ~36% of ICD patients and predicts worse MACE.
Why the study?
Common clinical indications for wideband CMR referral and its impact on clinical decision-making and prognosis in patients with ICDs were not well defined.
Does wideband cardiac magnetic resonance imaging impact diagnosis, clinical decision-making, and predict outcomes in patients with implantable cardioverter defibrillators?
Cohort (n=179)
Does wideband cardiac magnetic resonance imaging impact diagnosis, clinical decision-making, and predict outcomes in patients with implantable cardioverter defibrillators?
p-value: p=0.006
Wideband LGE CMR in patients with ICDs frequently leads to new diagnoses, changes in clinical management, and provides significant prognostic information regarding MACE.
May support diagnostic and prognostic use of wideband LGE CMR in ICD patients; leaves open need for prospective trials before practice change.
AIMS: Although myocardial scar assessment using late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) imaging is frequently indicated for patients with implantable cardioverter defibrillators (ICDs), metal artefact can degrade image quality. With the new wideband technique designed to mitigate device related artefact, CMR is increasingly used in this population. However, the common clinical indications for CMR referral and impact on clinical decision-making and prognosis are not well defined. Our study was designed to address these knowledge gaps. METHODS AND RESULTS: One hundred seventy-nine consecutive patients with an ICD (age 59 ± 13 years, 75% male) underwent CMR using cine and wideband pulse sequences for LGE imaging. Electronic medical records were reviewed to determine the reason for CMR referral, whether there was a change in clinical decision-making, and occurrence of major adverse cardiac events (MACEs). Referral indication was the most common evaluation of ventricular tachycardia (VT) substrate (n = 114, 64%), followed by cardiomyopathy (n = 53, 30%). Overall, CMR resulted in a new or changed diagnosis in 64 (36%) patients and impacted clinical management in 51 (28%). The effect on management change was highest in patients presenting with VT. A total of 77 patients (43%) experienced MACE during the follow-up period (median 1.7 years), including 65 in patients with evidence of LGE. Kaplan-Meier analysis showed that ICD patients with LGE had worse outcomes than those without LGE (P = 0.006). CONCLUSION: The clinical yield from LGE CMR is high and provides management changing and meaningful prognostic information in a significant proportion of patients with ICDs.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted a cohort in Patients with implantable cardioverter defibrillators (ICDs) (n=179). Wideband late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) vs. Patients without LGE was evaluated on Change in clinical decision-making, new or changed diagnosis, and major adverse cardiac events (MACEs) (p=0.006). Wideband LGE CMR resulted in a new or changed diagnosis in 36% of ICD patients, impacted clinical management in 28%, and the presence of LGE predicted worse MACE outcomes (P=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: